Insights - BIO

Areas of Work

	BIO Statement Regarding 2002 Planting Estimates for Genetically Modified Crops Mar 28 2002 WASHINGTON (March 28, 2002) -- (Dr. Michael P. Phillips, executive director for food and agriculture of the Biotechnology Industry Organization (BIO) issued the following...
	Toronto to Host BIO 2002 Mar 28 2002 WASHINGTON, D.C. (March 28, 2002) – The 16th annual International Biotechnology Convention and Exhibition, BIO 2002, will be held June 9-12 at the Metro Toronto Convention Centre in Toronto,...
	BIO President Comments on NIH Director, Surgeon General Nominees Mar 26 2002 Washington, D.C. (March 26, 2002)- BIO President Carl B. Feldbaum today issued the following statement on President Bush’s nominations for NIH director, Elias Zerhouni, M.D., chairman of...
	BIO 2002 Preview Program Now Available Mar 25 2002 WASHINGTON, D.C. (March 25, 2002) - The preview program for the BIO 2002 International Biotechnology Convention & Exhibition, including confirmed speakers, is now available online at www.bio.org...
	On-Line Media Registration For BIO 2002 Ends May 24 Mar 16 2002 Washington, D.C. (March 16, 2002)- The deadline for on-line registration for those seeking media credentials for BIO 2002 in Toronto is Friday, May 24, 2002. This is also the last date for...
	Discussions Produce Set Of Recommendations For PDUFA Renewal Mar 13 2002 Washington, D.C. (March 13, 2002)-The Biotechnology Industry Organization (BIO) announced today that discussions with the Food and Drug Administration and the Pharmaceutical Research and...
	I3C Announces Board of Directors Mar 12 2002 WASHINGTON, D.C. (March 12, 2002) - The Interoperable Informatics Infrastructure Consortium (I3C) which was incorporated on Feb. 13, 2002, held its first official board meeting Monday, March 11, in...
	BIO 2002 Advance Program Available Online Mar 7 2002 WASHINGTON, D.C. (March 7, 2002) – The advance program for the BIO 2002 International Biotechnology Convention & Exhibition is available online at www.bio2002.org. The conference will be held...
	Brownback Bill Threatens Major Medical Advances Mar 5 2002 March 5, 2002 (Washington, D.C.)-In conjunction with today’s hearing by the Senate Health, Education, Labor and Pensions Committee on “The Dangers of Cloning and the Promise of...
	BIO to Testify at House Hearing on User Fee Reauthorization Mar 5 2002 WASHINGTON, D.C. (March 5, 2002) - Mary Pendergast, executive vice president for government affairs at Elan Pharmaceuticals, will testify tomorrow on behalf of the Biotechnology Industry...